Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2013
11/28/2013WO2013129978A3 Nano-antibody, specifically binding muc1 protein, and method for detecting muc1 protein with the aid of the nano-antibodies
11/28/2013WO2013125988A3 Single-domain antibody specifically binding to s100a4/mts1 protein and use of said antibody to detect said protein
11/28/2013WO2013119964A3 Identification and enrichment of cell subpopulations
11/28/2013WO2013115897A3 Pathogen detection using metal enhanced fluorescence
11/28/2013WO2013070779A3 Handheld blood glucose monitoring device with messaging capability
11/28/2013WO2012038068A8 Means and methods for the prediction of treatment response of a cancer patient
11/28/2013WO2011151148A3 Method of toxicological evaluation, method of toxicological screening and associated system
11/28/2013WO2002059349A8 Odorant receptors and uses thereof
11/28/2013US20130318648 Diagnosis and therapeutic epitope, and transgenic plant
11/28/2013US20130318642 Methods of Screening Agents for Activity Using Teleosts
11/28/2013US20130317757 Exhaust sampling system and method for water vapor management
11/28/2013US20130317569 Optogenetic Control of Reward-Related Behaviors
11/28/2013US20130317321 Diver Monitoring and Communication System
11/28/2013US20130317217 Affinity adsorbents for fibrinogen
11/28/2013US20130317199 Antibodies To Alpha-Synuclein
11/28/2013US20130317107 Platelet-Based Methods to Detect and Monitor Treatment Benefits in Mucosal and Nervous Systems Diseases
11/28/2013US20130317103 NRF2 Screening Assays and Related Methods and Compositions
11/28/2013US20130317042 Method of Treating Ischemia/Reperfusion Injury
11/28/2013US20130317030 Methods for Diagnosis of Cardiovascular Disease
11/28/2013US20130316983 Drug screening method, compositions and methods of treating glaucoma
11/28/2013US20130316958 Highly potent peptides to control cancer and neurodegenerative diseases
11/28/2013US20130316948 Growth hormone receptor deficiency causes a major reduction in pro-aging signaling, cancer and diabetes in humans
11/28/2013US20130316935 Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
11/28/2013US20130316934 Systems and methods for detection of particles in a beneficial agent
11/28/2013US20130316932 Glycopeptide array
11/28/2013US20130316930 Process and kit for determining in vitro the immune status of an individual
11/28/2013US20130316928 Reagent storage in an assay device
11/28/2013US20130316926 Method for the monitoring of smoking cessation compliance and recovery, therapeutic intervention, and risk management
11/28/2013US20130316921 Methods for diagnosis of kawasaki disease
11/28/2013US20130316919 Biomarkers for the diagnosis of multiple sclerosis
11/28/2013US20130316912 Polymerase enzyme substrates with protein shield
11/28/2013US20130316468 Biomarkers for Alzheimer's Disease
11/28/2013US20130316464 Analyte extraction apparatus and method
11/28/2013US20130316463 Method for the purification of a glycan and/or a glycoconjugate by chromatography using a stationary phase comprising cotton
11/28/2013US20130316462 Rapid and high-throughput analysis of sterols/stanols or derivatives thereof
11/28/2013US20130316461 Sample analyzer, sample container for quality control, quality control method
11/28/2013US20130316432 Inhibitors of extracellular proteases
11/28/2013US20130316392 In vitro tumor in dish kit and method
11/28/2013US20130316391 Cells having disrupted expression of proteins involved in adme and toxicology processes
11/28/2013US20130316390 Method for diagnosis and/or prognosis of cancers by analysis of the mechanical properties of tumour cells
11/28/2013US20130316389 Method and System for Determining Characteristics of an Embryo and Uses Thereof
11/28/2013US20130316388 Process and apparatus for rapid, high-throughput analysis of fatty acids
11/28/2013US20130316384 Ice-cleaved alpha-synuclein as a biomarker
11/28/2013US20130316382 Method for evaluating the vital prognosis of a subject in a critical condition
11/28/2013US20130316381 Method and reagent device for determining anti-ra33 antibody igg
11/28/2013US20130316380 Methods and Assays for Measuring p95 and/or p95 Complexes in a Sample and Antibodies Specific for p95
11/28/2013US20130316379 Moesin fragments associated with immune thrombocytopenia
11/28/2013US20130316378 Methods of diagnosing acute cardiac disorders using bnp-sp
11/28/2013US20130316377 Methods for predicting and treating myocardial damage
11/28/2013US20130316375 Diabetes biomarkers
11/28/2013US20130316374 Breast cancer diagnostics
11/28/2013US20130316373 Separation of living untouched neurons
11/28/2013US20130316372 Method of Differentiating Oncogenic Changes of the Thyroid, A Kit to Embody the Method and the Use of Metallothionein (MT) for Differentiating Oncogenic Changes of the Thyroid
11/28/2013US20130316371 Test kit for plasma or serum antibody titer against periodontal disease-causing bacteria
11/28/2013US20130316370 Methods and compositions for diagnosis and prognosis of renal injury and renal failure
11/28/2013US20130316369 Method for detecting escherichia coli
11/28/2013US20130316368 Multi-target photonic biosensor, and method for manufacturing and preparing same
11/28/2013US20130316366 Expression of secreted and cell-surface polypeptides
11/28/2013US20130316361 Method for the diagnosis of a carcinoma and uses thereof
11/28/2013US20130316359 Method for determining cancer prognosis
11/28/2013US20130316349 N-methylpurine dna glycosylase and polymerase beta as biomarkers for alkylator chemotherapy potentiation
11/28/2013US20130316347 Process for multi-analyses of rare cells extracted or isolated from biological samples through filtration
11/28/2013US20130316338 CCR6 As A Biomarker of Alzheimer's Disease
11/28/2013US20130316337 Methods of Diagnosing and Treating an Inflammatory Response
11/28/2013US20130316327 Nmr diagnostics by means of a plastic sample container
11/28/2013US20130316326 Animal model for the evaluation of the efficacy of an hiv vaccine
11/28/2013US20130316008 Multicompartmentalized vesicular structure and a method for forming the same
11/28/2013US20130315981 Method for inducing fat loss in mammals
11/28/2013US20130315974 Non-Hormonal Female Contraceptive
11/28/2013US20130315958 Pneumococcal serotypes
11/28/2013US20130315944 Infectious genomic dna clone and serological profile of torque teno sus virus 1 and 2
11/28/2013US20130315940 Treatment of liver cancer
11/28/2013US20130315923 Anti-gcc antibody molecules and related compositions and methods
11/28/2013US20130315920 Cross Protective Epitopes of Aspergillus Fumigatus and Candida Albicans
11/28/2013US20130315915 Methods and compositions for diagnosing and treating diseases
11/28/2013US20130315913 Anti-light antibody therapy for inflammatory bowel disease
11/28/2013US20130315907 Vegf-a121 assay
11/28/2013US20130315899 Methods and compositions for diagnostic use in cancer patients
11/28/2013US20130315898 Biomarkers for asthma
11/28/2013US20130315896 Cytotoxicity Mediation of Cells Evidencing Surface Expression of CD44
11/28/2013US20130315881 Method and assay for glycosylation pattern detection related to cell state of stem cells
11/28/2013US20130315833 Methods of modulating cold sensory perception via a cold- and menthol-sensitive receptor (cmr1)
11/28/2013US20130315832 Device for analyzing the effects of at least one parameter relating to a volatile substance
11/28/2013US20130315830 PSMA as a BioMarker for Androgen Activity in Prostate Cancer
11/28/2013US20130315796 Biological cell separator and disposable kit
11/28/2013US20130315783 Sensor
11/28/2013US20130315278 Fuel composition identification system and method and fluid composition identification method
11/28/2013US20130313483 Multiphase systems and uses thereof
11/28/2013US20130312498 Cardiovascular disease risk assessment and treatment by sterol and/or stanol markers
11/28/2013US20130312497 Liquid quality checking device and liquid storage tank provided with the device
11/28/2013US20130312488 Smoke detection system and method for operating a smoke detection system
11/28/2013US20130312482 Analyzer calibrating system and exhaust gas analyzing system
11/28/2013DE112011101504T5 Verfahren und Vorrichtung zur Messung der Bodenmechanischen Eigenschaften Method and apparatus for measuring soil mechanical properties
11/28/2013DE102013209455A1 Probenfänger zum Auffangen eines Laser-Mikrodissektats Sample catcher to catch a laser Mikrodissektats
11/28/2013DE102012208865A1 Optical sensor for detection of substance in sample, has ring resonator whose portion comprises surface functionality that detects specific properties in variety of different molecules, and is provided with variety of surface modifications
11/28/2013DE102012110126B3 Optisches Element und optisches Sensorsystem Optical element and optical sensor system
11/28/2013DE102012104504A1 Marker substance for use in detection reagent of immunoassay for specific detection of biomaterial, has hetero element, subunit that is peptide, and reporter group that comprises chelating agent, complexing agent and ion exchanger
11/28/2013DE102012011411B3 Testsystem zum Portionieren, Mischen und Verteilen von biologischen Probenflüssigkeiten Test system for portioning, mixing and distribution of biological sample fluids
11/28/2013DE102012010470A1 Device for investigation of deformation behavior of textile semi-finished material, has deformation mechanism comprising deformation elements arranged relative to each other, so that component geometries are reproduced with mechanism
11/28/2013DE102008057797B4 Vorrichtung zur Probennahme von Metallschmelzen An apparatus for sampling molten metal